South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalDatas new report, South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the South and Central America In Vitro Diagnostics market Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

- Countries covered include Argentina, Brazil and Mexico.
- Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America In Vitro Diagnostics market..
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Bio-Rad Laboratories, Inc., Ortho-Clinical Diagnostics Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 In Vitro Diagnostics in South and Central America 12
3.1 In Vitro Diagnostics Cross Country Comparison, USD Actual, 2003-2017 12
3.2 In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017 13
3.3 In Vitro Diagnostics, South and Central America, Company share (2009-2010) 21
4 In Vitro Diagnostics In Brazil 23
4.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23
4.2 In Vitro Diagnostics, Brazil, Distribution Share (2009-2010) 29
4.2.1 Clinical Chemistry, Brazil, Distribution Share (2009-2010) 29
4.2.2 Genetic Testing , Brazil, Distribution Share (2009-2010) 29
4.2.3 Haematology , Brazil, Distribution Share (2009-2010) 30
4.2.4 Histology And Cytology , Brazil, Distribution Share (2009-2010) 30
4.2.5 Immuno Chemistry , Brazil, Distribution Share (2009-2010) 31
4.2.6 Infectious Immunology , Brazil, Distribution Share (2009-2010) 31
4.2.7 Microbiology Culture , Brazil, Distribution Share (2009-2010) 32
4.3 In Vitro Diagnostics, Brazil, Company share (2009-2010) 33
4.3.1 In Vitro Diagnostics, Brazil, Company share (2009-2010) 33
4.3.2 Clinical Chemistry, Brazil, Company share (2009-2010) 35
4.3.3 Genetic Testing, Brazil, Company share (2009-2010) 37
4.3.4 Haematology, Brazil, Company share (2009-2010) 39
4.3.5 Histology And Cytology, Brazil, Company share (2009-2010) 41
4.3.6 Immuno Chemistry, Brazil, Company share (2009-2010) 43
4.3.7 Infectious Immunology, Brazil, Company share (2009-2010) 45
4.3.8 Microbiology Culture, Brazil, Company share (2009-2010) 47
5 In Vitro Diagnostics In Argentina 48
5.1 In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017 48
5.2 In Vitro Diagnostics, Argentina, Distribution Share (2009-2010) 54
5.2.1 Clinical Chemistry , Argentina, Distribution Share (2009-2010) 54
5.2.2 Genetic Testing , Argentina, Distribution Share (2009-2010) 54
5.2.3 Haematology , Argentina, Distribution Share (2009-2010) 55
5.2.4 Histology and Cytology , Argentina, Distribution Share (2009-2010) 55
5.2.5 Immuno Chemistry , Argentina, Distribution Share (2009-2010) 56
5.2.6 Infectious Immunology , Argentina, Distribution Share (2009-2010) 56
5.2.7 Microbiology Culture , Argentina, Distribution Share (2009-2010) 57
5.3 In Vitro Diagnostics, Argentina, Company share (2009-2010) 58
5.3.1 In Vitro Diagnostics, Argentina, Company share (2009-2010) 58
5.3.2 Clinical Chemistry, Argentina, Company share (2009-2010) 60
5.3.3 Genetic Testing, Argentina, Company share (2009-2010) 62
5.3.4 Haematology, Argentina, Company share (2009-2010) 64
5.3.5 Histology and Cytology, Argentina, Company share (2009-2010) 66
5.3.6 Immuno Chemistry, Argentina, Company share (2009-2010) 68
5.3.7 Infectious Immunology, Argentina, Company share (2009-2010) 70
5.3.8 Microbiology Culture, Argentina, Company share (2009-2010) 72
6 In Vitro Diagnostics In Mexico 74
6.1 In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017 74
6.2 In Vitro Diagnostics, Mexico, Distribution Share (2009-2010) 80
6.2.1 Clinical Chemistry, Mexico, Distribution Share (2009-2010) 80
6.2.2 Genetic Testing, Mexico, Distribution Share (2009-2010) 80
6.2.3 Haematology, Mexico, Distribution Share (2009-2010) 81
6.2.4 Histology And Cytology, Mexico, Distribution Share (2009-2010) 81
6.2.5 Immuno Chemistry, Mexico, Distribution Share (2009-2010) 82
6.2.6 Infectious Immunology, Mexico, Distribution Share (2009-2010) 82
6.2.7 Microbiology Culture, Mexico, Distribution Share (2009-2010) 83
6.3 In Vitro Diagnostics, Mexico, Company Share (2009-2010) 84
6.3.1 In Vitro Diagnostics, Mexico, Company Share (2009-2010) 84
6.3.2 Clinical Chemistry, Mexico, Company Share (2009-2010) 86
6.3.3 Genetic Testing, Mexico, Company Share (2009-2010) 88
6.3.4 Haematology, Mexico, Company Share (2009-2010) 90
6.3.5 Histology And Cytology, Mexico, Company Share (2009-2010) 92
6.3.6 Immuno Chemistry, Mexico, Company Share (2009-2010) 94
6.3.7 Infectious Immunology, Mexico, Company Share (2009-2010) 96
6.3.8 Microbiology Culture, Mexico, Company Share (2009-2010) 98
7 Overview of Key Companies in South and Central America In Vitro Diagnostics Market 100
7.1 F. Hoffmann-La Roche Ltd. 100
7.1.1 Company Overview 100
7.1.2 Share in the South and Central America In Vitro Diagnostics Market 100
7.2 Siemens Healthcare 101
7.2.1 Company Overview 101
7.2.2 Share in the South and Central America In Vitro Diagnostics Market 101
7.3 Abbott Laboratories 102
7.3.1 Company Overview 102
7.3.2 Share in the South and Central America In Vitro Diagnostics Market 102
7.4 bioMerieux S.A. 103
7.4.1 Company Overview 103
7.4.2 Share in the South and Central America In Vitro Diagnostics Market 103
7.5 Bio-Rad Laboratories, Inc. 104
7.5.1 Company Overview 104
7.5.2 Share in the South and Central America In Vitro Diagnostics Market 104
7.6 Ortho-Clinical Diagnostics Inc. 105
7.6.1 Company Overview 105
7.6.2 Share in the South and Central America In Vitro Diagnostics Market 105
7.7 Beckman Coulter, Inc. 106
7.7.1 Company Overview 106
7.8 HORIBA, Ltd. 106
7.8.1 Company Overview 106
7.9 Becton, Dickinson and Company 107
7.9.1 Company Overview 107
7.10 Sysmex Corporation 107
7.10.1 Company Overview 107
7.11 Alere Inc. 107
7.11.1 Company Overview 107
7.12 DiaSorin S.p.A 108
7.12.1 Company Overview 108
7.13 Thermo Fisher Scientific Inc. 108
7.13.1 Company Overview 108
7.14 Phadia AB 108
7.14.1 Company Overview 108
7.15 Qiagen N.V. 109
7.15.1 Company Overview 109
7.16 Gen-Probe Incorporated 109
7.16.1 Company Overview 109
7.17 PerkinElmer, Inc. 110
7.17.1 Company Overview 110
7.18 Mindray Medical International Limited 110
7.18.1 Company Overview 110
7.19 Grifols, S.A. 111
7.19.1 Company Overview 111
7.20 DIAGNOSTICA STAGO, Inc. 111
7.20.1 Company Overview 111
8 In Vitro Diagnostics Market Pipeline Products 112
8.1 Clinical Chemisty Market Pipeline Products 112
8.2 Immuno Chemistry Market Pipeline Products 115
8.3 Haematology Market Pipeline Products 118
8.4 Infectious Immunology Market Pipeline Products 120
8.5 Microbiology Culture Market Pipeline Products 124
8.6 Histology and Cytology Market Pipeline Products 125
8.7 Genetic Testing Market Pipeline Products 126
9 Financial Deals Landscape 130
9.1 Partnerships 130
9.1.1 Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 130
9.1.2 Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical 131
9.1.3 AmStem Announces Co-Marketing Agreement With Histostem 132
10 Appendix 133
10.1 Definitions of Markets Covered in the Report 134
10.1.1 In Vitro Diagnostics 134
10.2 Research Methodology 136
10.3 Secondary Research 136
10.4 Primary Research 137
10.5 Models 137
10.6 Forecasts 138
10.7 Expert Panels 138
10.8 GlobalData Consulting 138
10.9 Currency Conversion 139
10.10 Contact Us 139
10.11 Disclaimer 139

List of Table:

1.1 List of Tables
Table 1: In Vitro Diagnostics, Cross Country Comparison, USD Actual, 2003-2017 12
Table 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017 14
Table 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2003-2017 16
Table 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 18
Table 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 20
Table 6: In Vitro Diagnostics, South and Central America, Company share by Revenue ($m), USD Actual, 2009-2010 22
Table 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 24
Table 8: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 26
Table 9: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 28
Table 10: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 29
Table 11: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 29
Table 12: Haematology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30
Table 13: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30
Table 14: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
Table 15: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
Table 16: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 32
Table 17: In Vitro Diagnostics, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 34
Table 18: Clinical Chemistry, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 36
Table 19: Genetic Testing, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 38
Table 20: Haematology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 40
Table 21: Histology And Cytology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 42
Table 22: Immuno Chemistry, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 44
Table 23: Infectious Immunology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 46
Table 24: Microbiology Culture, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 47
Table 25: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017 49
Table 26: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Historic, 2003-2010 51
Table 27: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 53
Table 28: Clinical Chemistry, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 54
Table 29: Genetic Testing, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 54
Table 30: Haematology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
Table 31: Histology And Cytology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
Table 32: Immuno Chemistry, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 56
Table 33: Infectious Immunology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 56
Table 34: Microbiology Culture, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 57
Table 35: In Vitro Diagnostics, Argentina, Company share by Revenue ($m), USD Actual, 2009-2010 59
Table 36: Clinical Chemistry, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 61
Table 37: Genetic Testing, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 63
Table 38: Haematology, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 65
Table 39: Histology And Cytology, Argentina, Company Share by Revenue ($m), USD Actual 2009-2010 67
Table 40: Immuno Chemistry, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 69
Table 41: Infectious Immunology, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 71
Table 42: Microbiology Culture, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 73
Table 43: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017 75
Table 44: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Historic, 2003-2010 77
Table 45: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 79
Table 46: Clinical Chemistry, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 80
Table 47: Genetic Testing, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 80
Table 48: Haematology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 81
Table 49: Histology And Cytology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 81
Table 50: Immuno Chemistry, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 82
Table 51: Infectious Immunology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 82
Table 52: Microbiology Culture, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 83
Table 53: In Vitro Diagnostics, Mexico, Company Share by Revenue ($m), USD Actual, 2009-2010 85
Table 54: Clinical Chemistry, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 87
Table 55: Genetic Testing, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 89
Table 56: Haematology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 91
Table 57: Histology And Cytology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 93
Table 58: Immuno Chemistry, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 95
Table 59: Infectious Immunology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 97
Table 60: Microbiology Culture, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 99
Table 61: Clinical Chemisty Market Pipeline Products 112
Table 62: Immuno Chemistry Market Pipeline Products 115
Table 63: Haematology Market Pipeline Products 118
Table 64: Infectious Immunology Market Pipeline Products 120
Table 65: Microbiology Culture Market Pipeline Products 124
Table 66: Histology and Cytology Market Pipeline Products 125
Table 67: Genetic Testing Market Pipeline Products 126
Table 68: Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 130
Table 69: Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical 131
Table 70: AmStem Announces Co-Marketing Agreement With Histostem 132
Table 71: USD to Local Currency, South and Central America, Average Exchange Rate 2003-2010 139

List of Charts:

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Cross Country Comparison , USD Actual, 2003-2017 12
Figure 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017 13
Figure 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2003-2017 15
Figure 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 17
Figure 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 19
Figure 6: In Vitro Diagnostics, South and Central America, Company share (%), 2010 21
Figure 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23
Figure 8: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25
Figure 9: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27
Figure 10: In Vitro Diagnostics, Brazil, Company share (%), 2010 33
Figure 11: Clinical Chemistry, Brazil, Company share (%), 2010 35
Figure 12: Genetic Testing, Brazil, Company share (%), 2010 37
Figure 13: Haematology, Brazil, Company share (%), 2010 39
Figure 14: Histology And Cytology, Brazil, Company share (%), 2010 41
Figure 15: Immuno Chemistry, Brazil, Company share (%), 2010 43
Figure 16: Infectious Immunology, Brazil, Company share (%), 2010 45
Figure 17: Microbiology Culture, Brazil, Company share (%), 2010 47
Figure 18: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017 48
Figure 19: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Historic, 2003-2010 50
Figure 20: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 52
Figure 21: In Vitro Diagnostics, Argentina, Company share (%), 2010 58
Figure 22: Clinical Chemistry, Argentina, Company share (%), 2010 60
Figure 23: Genetic Testing, Argentina, Company share (%), 2010 62
Figure 24: Haematology, Argentina, Company share (%), 2010 64
Figure 25: Histology And Cytology, Argentina, Company Share (%), 2010 66
Figure 26: Immuno Chemistry, Argentina, Company share (%), 2010 68
Figure 27: Infectious Immunology, Argentina, Company share (%), 2010 70
Figure 28: Microbiology Culture, Argentina, Company share (%), 2010 72
Figure 29: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017 74
Figure 30: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Historic, 2003-2010 76
Figure 31: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 78
Figure 32: In Vitro Diagnostics, Mexico, Company Share (%), 2010 84
Figure 33: Clinical Chemistry, Mexico, Company Share (%), 2010 86
Figure 34: Genetic Testing, Mexico, Company Share (%), 2010 88
Figure 35: Haematology, Mexico, Company Share (%), 2010 90
Figure 36: Histology And Cytology, Mexico, Company Share (%), 2010 92
Figure 37: Immuno Chemistry, Mexico, Company Share (%), 2010 94
Figure 38: Infectious Immunology, Mexico, Company Share (%), 2010 96
Figure 39: Microbiology Culture, Mexico, Company Share (%), 2010 98
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 100
Figure 41: Siemens Healthcare, Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 101
Figure 42: Abbott Laboratories, Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 102
Figure 43: bioMerieux S.A., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 103
Figure 44: Bio-Rad Laboratories, Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 104
Figure 45: Ortho-Clinical Diagnostics Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 105

Incoming search terms:

• argentina distributor diagnostica
• enigma diagnostics value of shares

Related posts:

1. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
2. Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
3. South and Central America Diagnostic Imaging Market Outlook to 2017 – Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
4. Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
5. Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017